Aberrant expression and activity of lysyl oxidase-like 2 (LOXL2) as a secreted copper- and quinone-dependent enzyme is involved in pathological processes predominantly associated with the ECM remodeling, such as Wilson's disease, heart failure and cholestasis [[3], [4], [5]]. This evidence concerns the gene LOXL2 and Wilson disease.